Apply on Employer Site

Alzheimer's Treatment Centers of America · 2 days ago

Neurodegenerative Care Strategy Advisor - Healthcare Executive Advisory Board Member

United States

Part-time

Remote

Senior Level

Alzheimer’s Treatment Centers of America (ATCA) is focused on transforming the treatment of Alzheimer’s disease and related conditions through innovative care models and AI-driven solutions. The Neurodegenerative Care Strategy Advisor will support the strategic design and scaling of care models, working closely with clinical teams and executive leadership to enhance treatment pathways and clinical decision-making.

Health CareHospitalMedical

Responsibilities

Provide expert guidance on strategic approaches to treating Alzheimer’s disease, dementia, and related neurodegenerative conditions across multiple stages of progression

Advise on the development of standardized yet flexible care pathways that support early detection, intervention, treatment optimization, and longitudinal management

Guide how biomarkers, imaging, cognitive assessments, and patient history inform personalized treatment strategies within ATCA’s AI-driven platform

Review aggregated, de-identified outcomes data to ensure clinical effectiveness, safety, and continuous improvement in neurodegenerative care delivery

Collaborate with neurologists, pharmacists, technologists, and executive leadership to align neurodegenerative strategy with operational execution

Provide insight into emerging neurodegenerative research, therapies, and care innovations that may inform ATCA’s evolving treatment model

Support strategies that balance clinical rigor, patient quality of life, and sustainable care delivery over extended disease timelines

Qualification

Neurodegenerative disease managementLongitudinal care deliveryPrecision medicine integrationClinical outcomes oversightCare pathway designInterdisciplinary collaborationInnovation insightPatient quality of life

Required

Experienced clinicians, physician-leaders, or healthcare strategists with deep expertise in neurodegenerative disease management and longitudinal care delivery

Expert guidance on strategic approaches to treating Alzheimer's disease, dementia, and related neurodegenerative conditions across multiple stages of progression

Advising on the development of standardized yet flexible care pathways that support early detection, intervention, treatment optimization, and longitudinal management

Guiding how biomarkers, imaging, cognitive assessments, and patient history inform personalized treatment strategies within ATCA's AI-driven platform

Reviewing aggregated, de-identified outcomes data to ensure clinical effectiveness, safety, and continuous improvement in neurodegenerative care delivery

Collaborating with neurologists, pharmacists, technologists, and executive leadership to align neurodegenerative strategy with operational execution

Providing insight into emerging neurodegenerative research, therapies, and care innovations that may inform ATCA's evolving treatment model

Supporting strategies that balance clinical rigor, patient quality of life, and sustainable care delivery over extended disease timelines

Benefits

Equity Options: Receive stock options in recognition of your clinical leadership and advisory contributions to ATCA’s mission.

Investment Access: Select advisory board members may be offered access to ATCA’s current financing round. Participation is optional and independent of the advisory role.